Antipsychotics

Researchers find that support and self-care were helpful for users during discontinuation, but that mental health professionals were not very helpful.

A new film, "Cause of Death: Unknown" investigates the pharmaceutical industry and the deaths that have been caused by psychiatric drugs. The film will...

From Sapiens: Researchers are increasingly recognizing the role that social and environmental factors, including childhood abuse, stressful events, and poverty, play in the development of...

From National Post: Antipsychotic drugs are increasingly being prescribed to children as young as two for attention deficit hyperactivity disorder, aggression and behavior problems. A...

From Persistent Market Research: The global antipsychotics market is expected to grow significantly by 2021, with especially high growth rates in Europe and Asia. However,...

In this piece for STAT, Shirley S. Wang discusses the Hearing Voices Network and its non-pathologizing, rights-affirming approach to hearing voices and alternative realities. "Many recovered...

A large longitudinal study finds once more that being prescribed antipsychotics significantly increases the risk of diabetes.

From The Independent: Thousands of people with Lewy Body Dementia are being prescribed antipsychotic drugs, increasing their risk of death fourfold. "These medicines, prescribed to around...

From The Chronicle: The practice of pharmaceutical industry payments to academic researchers to help promote their drugs remains widespread. Requiring scientists to disclose their ties...

Review study compares outcomes of gradual vs. immediate antipsychotic discontinuation when switching from one drug to another.

From The Sydney Morning Herald: New data from Pharmaceutical Benefits Scheme shows that a total of 16,570 Australian toddlers, children, and teens under 17 were...

A large observational study published in CNS Drugs sheds light on serious adverse effects of the ‘gold standard’ antipsychotic Clozapine.

When the neuroleptics-are-necessary-to-treat-schizophrenia myth falls, psychiatry is finished. And that is why the Goff et al paper was produced: a desperate attempt to maintain its position by a profession that is truly on the ropes. For psychiatry this is a death-struggle.

Individuals with lived experience and clinicians share about barriers and facilitators to guided self-help CBT for voice hearing.

From National Post: Many physicians are prescribing a low dose of Seroquel, an atypical antipsychotic, to patients with insomnia. Experts warn that even a low...

From Reuters: Two youth legal advocacy groups have filed a lawsuit against Missouri for over-exposing foster children to psychotropic drugs. The lawsuit seeks a court...

Evidence of duplicate publishing in articles analyzing data from clinical trials testing second-generation antipsychotics for depression

Veterans diagnosed with PTSD and taking SSRIs, novel antidepressants, or atypical antipsychotics are more likely to develop dementia.

Jeffrey LIeberman and colleagues have published a paper in the American Journal of Psychiatry stating that there is no evidence that psychiatric drugs cause long-term harm, and that the evidence shows that these drugs provide a great benefit to patients. A close examination of their review reveals that it is a classic example of institutional corruption, which was meant to protect guild interests.

Higher levels of sedentary behavior are associated with poorer cognitive functioning in patients diagnosed with schizophrenia.

From Healio: Researchers recently found that veterans diagnosed with PTSD and prescribed antidepressants or atypical antipsychotics are at a higher risk for dementia than veterans...

From Aeon: While psychiatric drugs are often ineffective and can have serious side effects, there are many psychedelics and other illicit substances that have proven...

Important assessment tool found to underestimate the risk for fracture in patients on psychiatric medication.

The most worrying thing about the Goff et al paper is the minimisation of the evidence that antipsychotics produce brain shrinkage. There are no studies that show progressive brain changes in people diagnosed with schizophrenia or psychosis in the absence of antipsychotic treatment.

A new study published in JAMA Internal Medicine, the largest study of its kind, has shown it is possible to reduce the use of antipsychotics in nursing homes, by engaging their staff in a training program designed to target residents’ strengths and their unmet needs.